Arun Balakumaran
- Oncology top 0.5%
- Pathology and Forensic Medicine top 1%
- Immunology top 5%
- Molecular Biology top 10%
- Pulmonary and Respiratory Medicine top 5%
- Co-authors
- Pier Luigi ZinzaniMargaret A. ShippCraig H. MoskowitzPhilippe ArmandAlejandro D. RicartVincent RibragJean‐Marie MichotJohn Kuruvilla
- Topics
- Lymphoma Diagnosis and Treatment (29 papers)Bone health and treatments (20 papers)Cancer Immunotherapy and Biomarkers (14 papers)
- Partner nations
- United StatesFranceItaly
In The Last Decade
Arun Balakumaran
78 papers receiving 3.7k citations
Hit Papers
Peers
Comparison fields: 5 of 109
- Oncology 2.7k
- Pathology and Forensic Medicine 1.2k
- Immunology 897
- Molecular Biology 706
- Pulmonary and Respiratory Medicine 470
Countries citing papers authored by Arun Balakumaran
This map shows the geographic impact of Arun Balakumaran's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arun Balakumaran with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arun Balakumaran more than expected).
Fields of papers citing papers by Arun Balakumaran
This network shows the impact of papers produced by Arun Balakumaran. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arun Balakumaran. The network helps show where Arun Balakumaran may publish in the future.
Co-authorship network of co-authors of Arun Balakumaran
This figure shows the co-authorship network connecting the top 25 collaborators of Arun Balakumaran. A scholar is included among the top collaborators of Arun Balakumaran based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arun Balakumaran. Arun Balakumaran is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Allogeneic BCMA-targeting CAR T cells in relapsed/refractory multiple myeloma: phase 1 UNIVERSAL trial interim resultsbreakdown → | 168 |
| 2 | Phase II Study of the Efficacy and Safety of Pembrolizumab for Relapsed/Refractory Classic Hodgkin Lymphomabreakdown → | 694 |
| 3 | 1 | |
| 4 | 3 | |
| 5 | 1 | |
| 6 | 1 | |
| 7 | 41 | |
| 8 | 46 | |
| 9 | 22 | |
| 10 | 2 | |
| 11 | 27 | |
| 12 | 2 | |
| 13 | 2 | |
| 14 | 120 | |
| 15 | 19 | |
| 16 | 17 | |
| 17 | 83 | |
| 18 | 4 | |
| 19 | 50 | |
| 20 | 7 |
About Arun Balakumaran
Arun Balakumaran is a scholar working on Oncology, Genetics and Pathology and Forensic Medicine, having authored 78 papers that have together received 3.7k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (29 papers), Bone health and treatments (20 papers) and Cancer Immunotherapy and Biomarkers (14 papers). The work is most often cited by research in Oncology (2.7k citations), Pathology and Forensic Medicine (1.2k citations) and Immunology (897 citations). Arun Balakumaran has collaborated with scholars based in United States, France and Italy. Frequent co-authors include Pier Luigi Zinzani, Margaret A. Shipp, Craig H. Moskowitz, Philippe Armand, Alejandro D. Ricart, Vincent Ribrag, Jean‐Marie Michot, John Kuruvilla, Pamela Gehron Robey and Akihiro Tomita. Their work appears in journals such as Nature Medicine, Journal of Clinical Oncology and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.